Quick Links |
 |
Latest News
AntiMal PhD Programme - Alumni Newsletter
Attached is an update on the progress of the AntiMal PhD students
AntiMal has joined forces with the Royal Society of Chemistry to run a conference in 2011 to celebrate the achievements of the AntiMal project. The conference will take place at the Royal College of Physicians in London on the 15th and 16th March 2011.
Scientists develop new drug treatment for malaria
Scientists at the University of Liverpool and the Liverpool School of Tropical Medicine have produced a new antimalarial drug that is more chemically stable in the body than current malaria treatments.
Researchers from the University of Liverpool and the Liverpool School of Tropical Medicine have produced a new drug to treat malaria.
AntiMal News Letters
The AntiMal Newsletter provides a round up of all the years events, to read about our activities please follow the below links
| Issue 1 | August 2006 | Available for Download |  |
| Issue 2 | April 2007 | Available for Download | |
| Issue 3 | October 2008 | Available for Download | |
| Issue 4 | December 2009 | Available for Download | |
| Issue 5 | November 2010 | Available for Download | |
News Archive
Intellectual Property and Clincial Trials Course
In September 2010 members of the AntiMal consortium visited Gabon in Western Africa to meet up with the Medical Research Institute in Lamberene where we held a four day Intellectual Property (IP) and Clinical Trials course. Day 1 covered an introduction to IP and days 2 and 3 were devoted to Clinical Trials. On day 4 there was also an optional mornings visit to the clinical trial site in Lambaréné. The course was tailored to the needs of AntiMal partners and offered a unique opportunity to gain specific and relevant training in two areas that are essential to drug development.
AntiMal Symposia at the MIM Conference
The 5th Pan-African MIM conference was held at the Kenyatta Centre in Nairobi, Kenya from the 2nd to the 6th November. AntiMal took the podium, hosting two symposia on antimalarial drug development. Read More..
AntiMal Leadership Course
n October 2009 twenty-one members of the AntiMal consortium converged on the little village of Les Diablerets in the Swiss Alps for a leadership course. Read More...
ESAC Review March 2009
The goal of the AntiMal project is to establish a portfolio of new antimalarial drugs from within the European scientific community and to select candidates from within the portfolio for progression to “first into man” studies within the 5 year programme . Read More
New African Partners Join the AntiMal Consortium
The AntiMal consortium has expanded to 34 partners with the integration of three new partners from Africa.
AntiMal Project Management Workshop
This workshop was held in Nairobi, Kenya on 19th, 20th and 21st September 2007... Read More
Launch of Competitive Call for Funding of Antimalarial Drug Discovery in Sub-Saharan Africa
Funding of up to 1 million Euros over three years is available for research in Africa. The aim is to build long-term sustainable institutional capacity in the field of antimalarial drug discovery. Funding is supported by the EU FP6 financed AntiMal project in collaboration with MIM/TDR. The deadline for applications was 15th July 2007...
AntiMal GLP/GCP Workshop
This workshop was held on the 24th, 25th and 26th July 2007 at the Liverpool School of Tropical Medicine, UK ...